Notify me when MAK Capital Fund LP files a new Schedule 13D/G report.
⭐ Subscribe ⭐| Sym | Company | Class | Ownership | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|---|
| AUTL | Autolus Therapeutics plc | Ordinary Shares, nominal value $0.000042 per share, and American Depositary Shares ("ADS"). Each ADS represents one Ordinary Share | 10.1% | $34.4M | $14.7M | 26.9M | +74.5% | MAK Capital Fund LP | Dec 1, 2025 |
| HSII | HEIDRICK & STRUGGLES INTERNATIONAL INC | Common Stock, $0.01 par value | 5.8% | $60.4M | $6.88M | 1.21M | +12.8% | MAK Capital Fund LP | Oct 27, 2025 |
| Sym | Target | Class | Ownership | Change | Current Shares | Change | Value | Reporting name | Form | Report Period | Date Filed |
|---|